CEBPA mutation analysis

Alphabetical Test listing

CEBPA mutation analysis-13554

  
CEBPA mutation analysis
  
13554
  
LAB13554
  
CEBPA
  

The CEBPA (CCAAT/enhancer binding protein alpha) gene encodes a transcription factor important for granulocyte differentiation. CEBPA mutations are found in 6-15% of de novo acute myeloid leukemia (AML) and in 15-18% of AML with normal karyotypes. CEBPA mutations are associated with favorable prognosis in absence of associated cytogenetic abnormalities and FLT3 internal duplication (FLT3-ITD). Germline CEBPA mutations are a cause of nonsyndromic, familial AML.

  
EDTA whole blood
  
  
5 mL
  
3 mL
  

Lavender (EDTA), 4 mL

 

  
Sodium heparin (Na hep) whole blood
Bone marrow
  
  
Bone marrow - 2 mL (minimum 1.0 mL)
  

Whole blood

Dk green Sodium heparin (Na hep), no gel

Bone marrow

Lavender (EDTA), 4mL

Dk green Sodium heparin (Na hep), no gel

 

  

Molecular Medicare billing request

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed
  

Ambient (preferred)

  

Specimen does not meet all of the above criteria for sample type, container, minimum volume, collection and storage.

Unsuitable specimens include but are not limited to:

  • frozen whole blood or marrow
  • a leaking tube
  • clotted blood or marrow
  • a grossly hemolyzed specimen or otherwise visibly degraded
  • specimen suspected of being contaminated by another specimen
  • specimen contains specific foreign material
  
LabCorp RTP (489170): R-LC
  
Mo - Fr
  
10 - 14 days
  

Polymerase chain reaction (PCR), direct sequencing and capillary electrophoresis

  

An interpretive report will be included

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81218
  
Yes
  
  
Result 64012-8
  
03/29/2019
  
10/05/2020
  
02/19/2021